This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sustained-Release Dexamethasone

pSivida Corporation

Drug Names(s): Sustained release dexamethasone

Description: pSivida is evaluating a sustained release form of dexamethasone using a screw implant. The implant is surgically implanted into the non-articulating area of the knee in an outpatient procedure.

Sustained-Release Dexamethasone News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug